ArticleOpen forum infectious diseases2019

Restoration of Bacterial Microbiome Composition and Diversity Among Treatment Responders in a Phase 2 Trial of RBX2660: An Investigational Microbiome Restoration Therapeutic.

Ken F Blount et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.